ML19240B518

09/12/2019 Public Teleconference Meeting with Exubrion Therapeutics, Inc

ML19240B518
Person / Time
Issue date:	08/28/2019
From:	Office of Nuclear Material Safety and Safeguards
To:
References
PMNS20190955
Download: ML19240B518 (3)

Text

PUBLIC MEETING ANNOUNCEMENT Title: Public Teleconference Meeting with Exubrion Therapeutics, Inc.

September 12, 2019, 01:00 PM to 02:00 PM Date(s) and Time(s):

Location: Teleconference Category: This is a Category 1 meeting. The public is invited to observe this meeting and will have one or more opportunities to communicate with the NRC after the business portion of the meeting but before the meeting is adjourned.

Purpose: The purpose of the meeting is to review options for Exubrion Therapeutics, Inc.'s continued discussions on the use of Sn-117m in dogs for the treatment of osteoarthritis.

Contact: Irene Wu 301-415-1951 Irene.Wu@nrc.gov NRC Office of Nuclear Material Safety and Safeguards Participants:

Teleconference:

Bridge Number Pass Code (888) 677-2595 69556

PUBLIC MEETING AGENDA

Public Teleconference Meeting with Exubrion Therapeutics, Inc.

September 12, 2019, 01:00 PM to 02:00 PM Teleconference The time of the meeting is local to the jurisdiction where the meeting is being held.

The NRC provides reasonable accommodation to individuals with disabilities where appropriate. If reasonable accommodation is needed to participate in this meeting, or if a meeting notice, transcript, or other information from this meeting is needed in another format (e.g., Braille, large print), please notify the NRC meeting contact.

Determinations on requests for reasonable accommodation will be made on a case-by-case basis.

ADAMS Accession Number:

ML19240B518 OFFICIAL RECORD COPY https://www.nrc.gov/pmns/mtg?do=details&Code=20190955 Link to meeting details:

Commission's Policy Statement on "Enhancing Public Participation in NRC Meetings" 67 Federal Register 36920, May 28, 2002 The policy statement may be found on the NRC website http://www.nrc.gov/reading-rm/doc-collections/commission/policy/67fr36920.html